Anthralin

Anthralin

SCHEMBL3197

O=C1c2c(O)cccc2Cc2cccc(O)c21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 1.00
KMT2A Q03164 5/20 1.00
ALDH1A1 P00352 4/20 1.00
TDP1 Q9NUW8 4/20 1.00
USP2 O75604 4/20 1.00
MEN1 O00255 4/20 1.00
ALOX15 P16050 3/20 1.00
HSD17B10 Q99714 3/20 1.00
TSHR P16473 3/20 1.00
CYP3A4 P08684 3/20 1.00
THRB P10828 2/20 1.00
HPN P05981 1/20 1.00
ALOX5 P09917 1/20 1.00
PTGS1 P23219 1/20 1.00
PDE4A P27815 1/20 1.00
KDR P35968 1/20 1.00
SIRT5 Q9NXA8 1/20 1.00
L3MBTL1 Q9Y468 1/20 1.00
HRH3 Q9Y5N1 1/20 1.00
TNF P01375 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anthralin SCHEMBL29439039 1.00 MAPT (1.00) MAPTKMT2AALDH1A1TDP1USP2
Anthralin SCHEMBL30013383 1.00 MAPT (1.00) MAPTKMT2AALDH1A1TDP1USP2
Anthralin SCHEMBL7555831 0.98 MAPT (0.96) MAPTKMT2AALDH1A1TDP1USP2
Anthralin SCHEMBL188254 0.92 MAPT (0.85) MAPTKMT2AALDH1A1TDP1USP2
SCHEMBL1204733 0.86 MAPT (0.75) MAPTKMT2AALDH1A1TDP1USP2
SCHEMBL29549838 0.86 MAPT (0.75) MAPTKMT2AALDH1A1TDP1USP2
SCHEMBL12023167 0.85 ALDH1A1 (0.74) MAPTKMT2AALDH1A1TDP1USP2
SCHEMBL31509436 0.84 ALDH1A1 (0.71) MAPTKMT2AALDH1A1TDP1USP2
SCHEMBL1003557 0.84 ALDH1A1 (0.71) MAPTKMT2AALDH1A1TDP1USP2
SCHEMBL29929084 0.84 ALDH1A1 (0.71) MAPTKMT2AALDH1A1TDP1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 15521 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260137680-A1 NOVEL COMPOUNDS SITRYX THERAPEUTICS LTD (GB) 2026-05-21 US claimed
US-20260138973-A1 SUBSTITUTED PYRIDINES FOR USE IN TREATING OR PREVENTING INFLAMMATORY DISEASES OR DISEASES ASSOCIATED WITH AN UNDESIRABLE IMMUNE RESPONSE SITRYX THERAPEUTICS LTD (GB) 2026-05-21 US claimed
EP-4743098-A1 THERAPEUTIC USE OF FIBROBLASTS FOR THE TREATMENT OF PSORIASIS FibroBiologics, Inc. (US) 2026-05-20 EP claimed
EP-4739291-A2 ADMINISTRATION OF KERATOLYTICS TO OCULAR AND PERIOCULAR SURFACES AZURA OPHTHALMICS LTD (IL) 2026-05-13 EP claimed
EP-4739293-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE DISORDERS AZURA OPHTHALMICS LTD (IL) 2026-05-13 EP claimed
US-12617762-B2 Carboxy derivatives with antiinflamatory properties SITRYX THERAPEUTICS LIMITED (GB) 2026-05-05 US claimed
US-20260092050-A1 CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF RAPT THERAPEUTICS INC (US) 2026-04-02 US claimed
US-20260085061-A1 PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS SITRYX THERAPEUTICS LIMITED (GB) 2026-03-26 US claimed
US-20260066253-A1 MASS SPECTROMETRY METHOD, DISCRIMINATION MODEL CREATION METHOD, FIBER DISCRIMINATION METHOD, PROGRAM, INFORMATION PROCESSING APPARATUS, AND FIBER DISCRIMINATION SYSTEM SHIMADZU CORPORATION (JP) 2026-03-05 US claimed
EP-4081511-B3 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES SITRYX THERAPEUTICS LTD (GB) 2026-03-04 EP claimed
US-4367224-A ANTIINFLAMMATORY AGENTS, SKIN DISORDERS SCOTT EUGENE J VAN 1983-01-04 US claimed
EP-0017420-B1 NEW DIHYDROXY-ACYLANTHRONES HAVING ANTI-PSORIATIC ACTIVITY, PROCESS FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM, AND THEIR USE AS ANTI-PSORIATIC AGENTS ORION-YHTYMÄ OY (FI) 1982-07-21 EP claimed
EP-0046270-A1 Novel derivatives of bio-affecting phenolic compounds and pharmaceutical composition containing them INTERx RESEARCH CORPORATION (US) 1982-02-24 EP claimed
US-4316902-A Therapeutic compositions and vehicles for topical pharmaceuticals YU RUEY J 1982-02-23 US claimed
US-4287214-A OR THE LACTONES OR AMIDES SAID HYDROXYACIDS SCOTT EUGENE J VAN 1981-09-01 US claimed
EP-0033075-A1 Substituted 1.8-dihydroxy-9-(10H)-anthracenones, process for their preparation and medicines containing these compounds Dr. Karl Thomae GmbH (DE) 1981-08-05 EP claimed
US-4252796-A ALUMINUM COMPOUNDS, ANTIINFLAMMATORY AGENTS YU RUEY J 1981-02-24 US claimed
EP-0017420-A1 New dihydroxy-acylanthrones having anti-psoriatic activity, process for preparing them, pharmaceutical compositions comprising them, and their use as anti-psoriatic agents ORION-YHTYMÄ OY (FI) 1980-10-15 EP claimed
US-4203969-A PSORIASIS DRYTHANOL LIMITED (GB) 1980-05-20 US claimed
US-3981996-A Pharmaceutical skin compositions VYMATT S.A. (CH) 1976-09-21 US claimed